DalsnaFinance

Evoworks Bio Selected for BARDA-Backed VANGUARD Program to Demonstrate Rapid, Scalable Production of Critical Biologics

Markets PR Newswire By PR Newswire 23 Jul 2026 12:00 1 min read
Evoworks Bio Selected for BARDA-Backed VANGUARD Program to Demonstrate Rapid, Scalable Production of Critical Biologics

A collaborative 6-month project advancing life science tools and diagnostics for health security in partnership with Kemp Proteins & Rockland Immunochemical FREDERICK, Md., July 23, 2026 /PRNewswire/ -- Evoworks Bio today announced its platform technology has been selected for BioTools...

A collaborative 6-month project advancing life science tools and diagnostics for health security in partnership with Kemp Proteins & Rockland Immunochemical FREDERICK, Md., July 23, 2026 /PRNewswire/ -- Evoworks Bio today announced its platform technology has been selected for BioTools...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.